The article is in their print magazine, not online yet. It usually takes some time until they feature articles from their print-mag on their website www.deraktionaer.de
"Der Aktionär" is one of the leading investor-mags in Germany, probably the most popular one amongst private investors.
The report is in their latest issue, it is a big article about swine-flu related stocks on pages 28-30.
They discuss the best stocks and introduce Biota to their readers, saying that Biota receives Relenza-royalties and that they expect strong Relenza-sales. They say that Biota-stock had a massive rise of 1500% since beginning of this year - but that they still see potential. They also underline the LANI-story with good Phase 3 results, Daiichi Sankyo-cooperation and mention, that the market speculates about LANI-deals in the big markets Europe and USA.
They recommend to BUY Biota, TARGET Euro 2,80 (A$ approx. 4,60).
BTA Price at posting:
$2.68 Sentiment: Hold Disclosure: Held
